Amrize AMRZ
Amrize Ltd is a Swiss building materials company that manufactures and distributes products for construction and infrastructure, with a business model focused on sales to construction professionals. Amrize shows solid financial health (ND/EBITDA 2.21) and attractive valuation (P/E 17.14, forward 13.06), but its quality is average (ROE 9.72) and the dividend is low (0.92%). The 28% drop and negative momentum (-5.14) reflect a weak 2026, although the CEO's share purchase and better prospects for 2027 suggest recovery potential.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Amrize Ltd is a Swiss building materials company that manufactures and distributes products for construction and infrastructure, with a business model focused on sales to construction professionals. Amrize shows solid financial health (ND/EBITDA 2.21) and attractive valuation (P/E 17.14, forward 13.06), but its quality is average (ROE 9.72) and the dividend is low (0.92%). The 28% drop and negative momentum (-5.14) reflect a weak 2026, although the CEO's share purchase and better prospects for 2027 suggest recovery potential.
Score by category
| Category | Score |
|---|---|
| Financial health | 6.5 |
| Quality / Moat | 4.9 |
| Valuation | 7.2 |
| Growth | 6.7 |
| Dividend | 2.5 |
| Momentum | 4.9 |
| Risk & Context | 4.2 |
OVERALL SCORE: 5.5/10
Context and risks
Moderate governance risk in Switzerland. Additionally, the company is at the 5th percentile of its 52-week range, reflecting a 28% decline and a weak 2026 business environment.
News considered in the analysis
- Amrize's 2027 Outlook Seen Improving After Weak 2026, UBS Says — Mejora de perspectivas para 2027 según UBS, pero es una previsión de analista, no un hecho consumado.
- Amrize (SWX:AMRZ) Stock Looks Below Fair Value After 28% Fall — Artículo de opinión sobre valoración, sin información nueva.
- Is Amrize (SWX:AMRZ) Undervalued As Leadership Changes Test Its Turnaround Story? — Análisis especulativo sobre el cambio de liderazgo, sin datos concretos nuevos.
- Amrize CEO Jan Philipp Jenisch Buys 30,000 Shares for $1.3 Million. Is This a Buy Signal? — Compra de acciones por el CEO por 1,3 millones de dólares: señal positiva de confianza interna, hecho ya ocurrido.
- Do Options Traders Know Something About Amrize Stock We Don't? — Titular especulativo sobre actividad de opciones, sin información sustancial.
Verdict: Hold or accumulate on dips, given the forward P/E of 13.06 and expected improvement for 2027, but monitor short-term business performance.
Main risk: The main risk is that 2026 weakness persists longer than expected, affecting the company's ability to meet recovery expectations for 2027, as reflected by negative momentum and the 5th percentile position in the 52-week range.
Other Basic Materials companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →